Cargando…

Prevalence and Risk Factors for Extended Spectrum Beta-Lactamase-Producing Uropathogens in Patients with Urinary Tract Infection

PURPOSE: The aim of this study was to determine the prevalence and risk factors of extended spectrum beta-lactamase (ESBL)-producing microorganisms in urinary tract infection. MATERIALS AND METHODS: total of 2,312 patients older than 25 years and diagnosed from January 2007 to December 2009 as havin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Dong Sup, Lee, Chung Bum, Lee, Seung-Ju
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907500/ https://www.ncbi.nlm.nih.gov/pubmed/20664784 http://dx.doi.org/10.4111/kju.2010.51.7.492

Ejemplares similares

Extended spectrum beta-lactamase urinary tract infections
por: Aboumarzouk, Omar M.
Publicado: (2014)

135 Fosfomycin Susceptibilities Among Uropathogenic Extended Spectrum Beta-Lactamase-producing Enterobacteriacea
por: Abbo, Lilian, et al.
Publicado: (2014)

Multidrug-resistant and extended-spectrum beta-lactamase-producing uropathogens in children in Bhaktapur, Nepal
por: Raya, Ganendra Bhakta, et al.
Publicado: (2020)

Treatment duration of complicated urinary tract infections by extended-spectrum beta-lactamases producing enterobacterales
por: Álvarez Otero, Judith, et al.
Publicado: (2020)

Prevalence of Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae Isolates in Nosocomial and Community-Acquired Urinary Tract Infections
por: Latifpour, Mohammad, et al.
Publicado: (2016)

Fosfomycin susceptibility among multidrug-resistant, extended-spectrum beta-lactamase-producing, carbapenem-resistant uropathogens
por: Banerjee, Sayantan, et al.
Publicado: (2017)

Prevalence of Quinolone Resistance Among Extended-Spectrum β -Lactamase Producing Uropathogenic Klebsiella pneumoniae
por: Raei, Fereshteh, et al.
Publicado: (2014)

Prevalence of extended-spectrum beta-lactamase-producing bacteria in food
por: Tham, Johan, et al.
Publicado: (2012)

Prevalence of extended spectrum beta-lactamase production among uropathogens in south Mumbai and its antibiogram pattern
por: Aruna, K., et al.
Publicado: (2012)

Experience with fosfomycin in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae
por: Bielen, Luka, et al.
Publicado: (2019)

Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli
por: Seo, Yu Bin, et al.
Publicado: (2017)

Characterization of Multidrug Resistant Extended-Spectrum Beta-Lactamase-Producing Escherichia coli among Uropathogens of Pediatrics in North of Iran
por: Rezai, Mohammad Sadegh, et al.
Publicado: (2015)

Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections
por: Vachvanichsanong, P., et al.
Publicado: (2020)

High prevalence of extensively drug resistant and extended spectrum beta lactamases (ESBLs) producing uropathogenic Escherichia coli isolated from Faisalabad, Pakistan
por: Ehsan, Beenish, et al.
Publicado: (2023)

Oral Amoxicillin-Clavulanic Acid Treatment in Urinary Tract Infections Caused by Extended-Spectrum Beta-Lactamase–Producing Organisms
por: Beytur, Ali, et al.
Publicado: (2014)

Extended-spectrum Beta-lactamase-producing Community-acquired Urinary Tract Infections in Children: Chart Review of Risk Factors
por: Balasubramanian, Sundaram, et al.
Publicado: (2018)

Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae in Fresh Produce
por: Pintor-Cora, Alberto, et al.
Publicado: (2021)

Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae
por: Han, Seung Beom, et al.
Publicado: (2015)

Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
por: Cho, Sung-Yeon, et al.
Publicado: (2016)

Prevalence of extended spectrum beta-lactamase producing anaerobic bacteria in chronic periodontitis
por: Benachinmardi, Kirtilaxmi Kenchappa, et al.
Publicado: (2014)

Comparison of host response mechanisms evoked by extended spectrum beta lactamase (ESBL)- and non-ESBL-producing uropathogenic E. coli
por: Demirel, Isak, et al.
Publicado: (2013)

Detection of Extended Spectrum β-lactamase Production Among Uropathogens
por: Aggarwal, Ritu, et al.
Publicado: (2009)

Outcome of Antimicrobial Therapy of Pediatric Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae
por: Lee, Bongjin, et al.
Publicado: (2013)

Extended-Spectrum-Beta-Lactamase Producing Bacteria Related Urinary Tract Infection in Renal Transplant Recipients and Effect on Allograft Function
por: Ramadas, Poornima, et al.
Publicado: (2014)

Analysis of drug resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in children with urinary tract infection
por: Keshi, Lu, et al.
Publicado: (2019)

Bacterial Profiles and Their Associated Factors of Urinary Tract Infection and Detection of Extended Spectrum Beta-Lactamase Producing Gram-Negative Uropathogens Among Patients with Diabetes Mellitus at Dessie Referral Hospital, Northeastern Ethiopia
por: Alemu, Mekuanent, et al.
Publicado: (2020)

qnr Prevalence in Extended Spectrum Beta-lactamases (ESBLs) and None-ESBLs Producing Escherichia coli Isolated from Urinary Tract Infections in Central of Iran
por: Pakzad, Iraj, et al.
Publicado: (2011)

Persistent Extended-Spectrum β-Lactamase Urinary Tract Infection
por: DeBusscher, Joan, et al.
Publicado: (2009)

Complicated urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli
por: Ranjan, K. P., et al.
Publicado: (2014)

488 Treatment Outcomes in Patients with Extended-Spectrum Beta-lactamase Producing Organisms
por: Lee, Eunbae, et al.
Publicado: (2014)

Computational Guided Drug Targets Identification against Extended-Spectrum Beta-Lactamase-Producing Multi-Drug Resistant Uropathogenic Escherichia coli
por: Kaur, Harpreet, et al.
Publicado: (2023)

In Vitro Efficacy of Flomoxef against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Associated with Urinary Tract Infections in Malaysia
por: Ngoi, Soo Tein, et al.
Publicado: (2021)

Persistent infection with metallo-beta-lactamase and extended spectrum β-lactamase producer Morganella morganii in a patient with urinary tract infection after kidney transplantation
por: Leylabadlo, Hamed Ebrahimzadeh, et al.
Publicado: (2016)

Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms
por: Mody, Rupal M, et al.
Publicado: (2007)

Extended-Spectrum Beta-lactamase Producers: Detection for the Diagnostic Laboratory
por: Sahni, Rani Diana, et al.
Publicado: (2018)

Prevalence of Plasmid-mediated Quinolone Resistance and Its Association with Extended-spectrum Beta-lactamase and AmpC Beta-lactamase in Enterobacteriaceae
por: Jeong, Haeng Soon, et al.
Publicado: (2011)

Temporal trends and risk factors for extended-spectrum beta-lactamase-producing Escherichia coli in adults with catheter-associated urinary tract infections
por: Spadafino, Joseph T, et al.
Publicado: (2014)

Febrile urinary-tract infection due to extended-spectrum beta-lactamase–producing Enterobacteriaceae in children: A French prospective multicenter study
por: Madhi, Fouad, et al.
Publicado: (2018)

Efficacy of cefoxitin for the treatment of urinary tract infection due to extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates
por: Senard, Olivia, et al.
Publicado: (2018)

Risk Factors of Extended-Spectrum Beta-Lactamases-Producing Escherichia coli Community Acquired Urinary Tract Infections: A Systematic Review
por: Larramendy, Stéphanie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_olnh6j2i91ei3mcpcu63dk8k78